Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality.
about
A new paradigm for XOR-catalyzed reactive species generation in the endotheliumIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesAssociation of Toll-like receptor signaling and reactive oxygen species: a potential therapeutic target for posttrauma acute lung injury.Global metabolomic analysis of human saliva and plasma from healthy and diabetic subjects, with and without periodontal diseaseClinicians' response to hyperoxia in ventilated patients in a Dutch ICU depends on the level of FiO2.Parenteral nutrition with n-3 lipids in sepsis.Oxidative stress in airways: is there a role for extracellular superoxide dismutase?Airway purinergic responses in healthy, atopic nonasthmatic, and atopic asthmatic subjects exposed to ozone.Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactionsCalcium and reactive oxygen species in acute pancreatitis: friend or foe?Metabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation.Vascular physiology and pathology of circulating xanthine oxidoreductase: from nucleotide sequence to functional enzyme.Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis.Glutathione supplementation attenuates lipopolysaccharide-induced mitochondrial dysfunction and apoptosis in a mouse model of acute lung injury.Is there a role for beta-adrenoceptor agonists in the management of acute lung injury and the acute respiratory distress syndrome?Hydrogen peroxide-induced calcium influx in lung microvascular endothelial cells involves TRPV4.Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.NADPH oxidase and Nrf2 regulate gastric aspiration-induced inflammation and acute lung injury.Xanthine oxidoreductase-catalyzed reduction of nitrite to nitric oxide: insights regarding where, when and how.Oxidation of plasma cysteine/cystine redox state in endotoxin-induced lung injuryXanthine oxidoreductase in respiratory and cardiovascular disorders.Xanthine oxidoreductase-catalyzed reactive species generation: A process in critical need of reevaluation.Modification of surfactant protein D by reactive oxygen-nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivo.Transepithelial migration of neutrophils: mechanisms and implications for acute lung injuryLoss of caveolin-1 and adiponectin induces severe inflammatory lung injury following LPS challenge through excessive oxidative/nitrative stress.Preventive Effects of Carnosine on Lipopolysaccharide-induced Lung Injury.Nitrite reduction by molybdoenzymes: a new class of nitric oxide-forming nitrite reductases.Dispelling dogma and misconceptions regarding the most pharmacologically targetable source of reactive species in inflammatory disease, xanthine oxidoreductase.Biomarkers for differentiation of causes of respiratory distress in dogs and cats: Part 2--Lower airway, thromboembolic, and inflammatory diseases.Alcohol Abuse is Associated with Enhanced Pulmonary and Systemic Xanthine Oxidoreductase Activity.Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis.Antioxidant Vitamins and Trace Elements in Critical Illness.Plasma level of hypoxanthine/xanthine as markers of oxidative stress with different stages of obstructive sleep apnea syndrome.Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia.Role of free radicals in vascular dysfunction induced by high tidal volume ventilation.Effects of chronic hepatic dysfunction on pulmonary glutathione homeostasis.Mononuclear phagocyte xanthine oxidoreductase contributes to cytokine-induced acute lung injury.Binding of xanthine oxidase to glycosaminoglycans limits inhibition by oxypurinol.Evaluation of iron, transferrin and ferritin serum levels in patients with severe sepsis and septic shock.Endotoxemia alters nucleotide hydrolysis in platelets of rats.
P2860
Q26796264-C11825BD-9EBA-49E9-9816-367F8B466C46Q28388335-23A9AC10-3E82-442A-9477-BEE46F004327Q34035581-3AB4DFA0-AF60-460C-A51E-1FD6BBA0A6BFQ34061753-D3B0C719-0164-4981-9A80-3747BAAA2B53Q34486851-35C2903C-360C-44A7-A26D-D2E9B7DD0AA3Q34564520-83D58B5E-C35B-4513-9B72-A67540E7F1B1Q35019724-A7477C8B-0C1E-4A74-AE4F-50CADA217269Q35219204-E71EDD98-5DF2-43C8-9656-1CB3C608AD16Q35238645-FBA7DCED-744E-42F7-80F8-527EAC3EB211Q35245361-1F64FEA3-B287-4948-9383-113C8E4CF54BQ35675928-3802B1F6-72F6-4250-BE04-C9AA76703CD5Q35824883-E4758C0F-6E92-4C74-B808-95739D6C4400Q35914614-0C703FB8-E792-4353-98B8-829C68E13F8AQ35990568-D43F2754-F45B-4CE5-B9F3-6D09CABB8423Q36246746-3BF1321D-86D9-42EB-8935-1A71080AC547Q36382147-12768E14-F388-47FE-80C2-E9C38836FB89Q36467694-C7727E04-75E0-4AB8-9945-C7E055881C95Q36586166-7DE8178F-5FB8-4135-BBF8-B695D5B62100Q36997192-28FFD300-8399-4C9F-AB2B-61CF5D29749FQ37023323-DB48DDB9-0DBA-4FF9-BB70-0EF5AD9FBB79Q37111434-855F4A42-3005-46CB-95FE-E36B8E2348BFQ37133541-934CE784-4D8F-4863-B3DA-E2986564329FQ37159201-C908D825-80A2-40C1-8DED-7E2D3BD84830Q37180272-B5F2BDDE-C9D5-4F67-BEDE-ED5C3E397181Q37629301-3A94C0F7-4896-4936-A750-75FA55CD66FBQ37644140-3CDA4A5E-8B6E-4AA3-B341-760D2863B3A2Q38318607-A983039B-13D1-4844-ADCE-9B0BE55E46C6Q38494677-5792EF41-7E34-4B0B-93D6-5881935102C3Q38514907-71C9940B-BD13-489D-AE23-827A2ACBD0B0Q38609440-B33F1A3F-1706-4907-8CF2-553A4B635E88Q38796210-8344E146-C07D-4130-B350-42C71CDEA7BCQ38867571-2284CEF0-9B6C-4848-87BF-017137BD5561Q41156779-2ACF37A5-D970-40E9-AE88-29B7A850A961Q43559701-A978E824-AD87-497A-BCC1-79B1A3F84B2CQ43748351-DF10EE24-61C1-467F-98AC-ADA2D3A6CCB0Q44261105-E16343B1-CC92-4A06-A4D5-8AEB7DC086A6Q44598267-1B1EDAE6-696D-4568-AD96-8B7BE80BDDD5Q44962055-28B64197-33FB-442D-A4DC-F6745383A1D3Q45933826-4AC1E20A-FB93-4CC8-9BA4-41F3092410CDQ46113390-C768C771-43AF-43D0-82FC-E48FE15CDD86
P2860
Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Plasma hypoxanthine levels in ...... ess, morbidity, and mortality.
@en
Plasma hypoxanthine levels in ...... ess, morbidity, and mortality.
@nl
type
label
Plasma hypoxanthine levels in ...... ess, morbidity, and mortality.
@en
Plasma hypoxanthine levels in ...... ess, morbidity, and mortality.
@nl
prefLabel
Plasma hypoxanthine levels in ...... ess, morbidity, and mortality.
@en
Plasma hypoxanthine levels in ...... ess, morbidity, and mortality.
@nl
P2093
P1476
Plasma hypoxanthine levels in ...... ress, morbidity, and mortality
@en
P2093
P304
P356
10.1164/AJRCCM.155.2.9032182
P407
P577
1997-02-01T00:00:00Z